Mylan plant knocked for sloppy manufacturing controls in tainted valsartan fiasco

13th November 2019 Uncategorised 0

After the FDA issued a global recall last year of “sartan”-based drugs contaminated with a possible carcinogen, there’s been plenty of blame to pass around. The most recent recipient of regulators’ ire is Mylan, which was knocked with a warning letter criticizing procedures at an Indian plant.

More: Mylan plant knocked for sloppy manufacturing controls in tainted valsartan fiasco
Source: fierce